ALLMedicine™ Binge-eating Disorder Center
Research & Reviews 179 results
The International Journal of Eating Disorders; Kwag KH, Kim YR et. al.
Jun 11th, 2022 - We aimed to evaluate the feasibility, acceptability, and potential impact of a tele-guided digital-based intervention based on the addictive appetite model of recurrent binge eating. Female college students with bulimia nervosa (BN) or binge-eatin...
The International Journal of Eating Disorders; Lammers MW, Vroling MS et. al.
Jun 7th, 2022 - To evaluate whether the results of a quasi-randomized study, comparing dialectical behavior therapy for binge-eating disorder (DBT-BED) and an intensive, outpatient cognitive behavior therapy (CBT+) in individuals with BED, would be replicated in ...
Diabetic Medicine : a Journal of the British Diabetic Ass... Ritholz MD, Salvia MG et. al.
May 21st, 2022 - Although binge-eating disorder (BED) is a common comorbidity of type 2 diabetes, little is known about the treatment experiences for persons with both conditions. Our aim was to explore perceptions of Primary Care Providers' (PCPs') treatment amon...
Appetite Schneider E, Dourish CT et. al.
May 20th, 2022 - Obesity and Binge-Eating Disorder (BED) are prevalent conditions that are associated with increased risk of morbidity and mortality. There is evidence that the use of pharmacotherapy alongside behavioural treatments can improve quality of life and...
The British Journal of Clinical Psychology; Berking M, Eichler E et. al.
May 15th, 2022 - Deficits in emotion regulation (ER) have been shown to be associated with binge-eating disorder (BED). To further clarify the causal nature of this association, we tested whether systematically enhancing ER skills would reduce symptoms of BED. We ...
News 5 results
MDedge Psychiatry; Christopher Palmer
Jul 30th, 2019 - The Food and Drug Administration has accepted the new drug application for dasotraline for the treatment of moderate to severe binge-eating disorder, the drug’s developer, Sunovion, announced July 30. Dasotraline, a dopamine and norepinephrine reu.
MDedge Psychiatry; Lucas Franki
May 25th, 2016 - Binge-eating disorder is significantly more common using DSM-5 criteria than previously estimated, but the disorder is very rarely formally diagnosed, according to Nicole Cossrow, Ph. D.
Jun 5th, 2013 - HOLLYWOOD, FLA. – Not a single medication is approved for treatment of binge-eating disorder, but that could change if the favorable results of an ongoing phase III randomized trial of lisdexamfetamine mirror those of a recently completed phase II.
Family Practice News; Sarah Pressman Lovinger
CHICAGO — Treatment outcomes for obese patients with binge-eating disorder differ by disease severity and negative affect, data from a large study of patients with this disorder show. “We are trying to identify a particular subset of the populatio.
Sarah Pressman Lovinger
CHICAGO – Treatment outcomes for obese patients with binge-eating disorder differ by disease severity and negative affect, a large study of patients with this disorder shows. “We are trying to identify a particular subset of the population [that r.